Interestingly, activation of ERKs in pancreatic cancer and cell reprogramming takes place at different levels of the pathway: upstream by RAS or BRAF mutations and at the level of MAP-kinases by Dusp6 downregulation, respectively. This evidence concerns the gene BRAF and familial pancreatic carcinoma.